Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Daré Bioscience, Inc. (NASDAQ: DARE)
DARE Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
59.70%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
400%
DARE Stock Analysis
DARE
PE Ratio:
DARE
PEG Ratio:
Not Available
DARE
Forward EPS Growth (12 month):
0.00%
DARE
PS Ratio:
16.9
DARE
PSG Ratio:
0.2
DARE
Forward Revenue Growth (12 month):
74.40%
DARE Articles
No data was found